Our Services
There is an epidemic of chronic disease with a focus on late stage diagnosis and treatment versus prevention.
At Thyana Labs we can improve people’s health and lifespan through early detection and screening of cardiometabolic and inflammatory conditions with early comprehensive lab testing.
With personalized risk assessment we can implement evidence based lifestyle and treatment strategies to delay and prevent disease progression and illness.
The “Normal Cholesterol” Myth
Almost 50% of Americans have some form of chronic disease
Three core areas of chronic disease include cardiac, metabolic and inflammatory disease states which are interrelated
Standard risk assessment and lab testing such as the conventional lipid profile often miss underlying silent risk and overt disease
We know that approximately half of all people with heart attacks and strokes occur in people with “normal” cholesterol
Other novel and metabolic and inflammatory markers can help identify people at risk early in the disease process
Looking beyond lipids: Lp(a) and ApoB as disease markers
Lipoproteins such as Lp(a) and ApoB, as well as others, can identify high risk individuals with normal or mildly elevated cholesterol (LDL-C)
Standard risk assessment and lab testing such as the conventional lipid profile often miss underlying silent risk and overt disease
Employee’s PCP and health practitioners generally do not prescribe the additional testing required to detect the silent markers of the disease
Monitoring and testing made simple
Insulin resistance, prediabetes and diabetes are known risk factors for chronic disease
At Thyana Labs we can improve people health and lifespan through early detection and screening of cardio-metabolic and inflammatory conditions with early comprehensive lab testing
With personalized risk assessment we can implement evidence based lifestyle and treatment strategies to delay and prevent disease progression and illness
Why cardiac health matters to employers’ bottom line
-
CVD imposes a heavy financial toll on employers: Annual costs to American employers amount to billions of dollars, with projections indicating a tripling of these costs by 2030 - a 61% increase1. Total labor income losses were estimated at $203.3 billion for heart disease and $63.6 billion for stroke in 201825. CVD costs employers $147 billion in lost productivity annually. AHA Journal. Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement From the American Heart Association. 2011
-
For each dollar invested over a 2 to 5 year period, employers can see a yield of 3 dollar to 6 dollar return on investment in comprehensive worksite health-promotion programs. Matson Koffman DM, Goetzel RZ, Anwuri VV, Shore KK, Orenstein D, LaPier T. Heart healthy and stroke free: successful business strategies to prevent cardiovascular disease. Am J Prev Med. 2005 Dec;29(5 Suppl 1):113-21. doi: 10.1016/j.amepre.2005.07.017. PMID: 16389136.
-
Preventive care is the key to improved results. The current system forces the employees to navigate a maze of appointments with at least three different doctors. It's not just time-consuming—it's potentially dangerous. Each specialist focuses on their area, possibly missing crucial connections in the overall cardiac health. Thyana offers the opportunity to getting all the information employees need in one comprehensive step. It's not just convenient—it could be life-saving.
